Press release
Exocrine Pancreatic Insufficiency Treatment Market to Surge with 6.4% CAGR, Global Revenue to Exceed USD 5.37 billion by 2031 - AbbVie, Codexis Inc., Nestle.
Exocrine Pancreatic Insufficiency Treatment Market
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/exocrine-pancreatic-insufficiency-treatment-market
What is the projected growth rate (CAGR) of the Global Exocrine Pancreatic Insufficiency Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.
Exocrine pancreatic insufficiency (EPI) occurs when the pancreas doesn't produce enough digestive enzymes. Treatment typically includes enzyme replacement therapy, along with dietary adjustments to ensure nutrient absorption. This condition is often seen in chronic pancreatitis, cystic fibrosis, or diabetes. Managing EPI helps prevent malnutrition and supports overall digestive health.
Key Developments:
❁ In May 2024, Alcresta Therapeutics announced the commercial availability of the next-generation RELiZORB cartridge, which was cleared by the U.S. FDA's Center for Devices and Radiological Health (CDRH). This device is designed to help break down fat in enteral nutrition, improving nutrient absorption for patients with malabsorption conditions. The new version features advancements aimed at increasing efficiency and ease of use.
List of the Key Players in the Exocrine Pancreatic Insufficiency Treatment Market:
AbbVie, Codexis Inc., Nestle, Alcresta Therapeutics, Inc., First Wave BioPharma, Eli Lilly and Company, Cilian AG, Synspira Therapeutics, Perseo Pharma, and Vivus LLC.
Research Process:
Both primary and secondary data sources have been used in the global Exocrine Pancreatic Insufficiency Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Exocrine Pancreatic Insufficiency Treatment Market:
By Treatment: Drug Type, Creon, Zenpep, Pancreaze, Ultra, Viokace, Others, Nutritional management (Dietary Supplements), Pancreatic Enzyme Replacement Therapy.
By Application: Crohn's Disease, Ulcerative Colitis, GERD, IBS, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Breakout:
The global Exocrine Pancreatic Insufficiency Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=exocrine-pancreatic-insufficiency-treatment-market
Regional Analysis:
The global Exocrine Pancreatic Insufficiency Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Exocrine Pancreatic Insufficiency Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Exocrine Pancreatic Insufficiency Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Exocrine Pancreatic Insufficiency Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/exocrine-pancreatic-insufficiency-treatment-market
Frequently Asked Questions
1) What is the expected growth rate of the global market for the forecast period?
2) What are the key driving factors that are responsible to shape the fate of the Exocrine Pancreatic Insufficiency Treatment market during the forecast period?
3) What will be the overall size of the market during the analysis period?
4) What are the prominent market trends which influence the development of the Exocrine Pancreatic Insufficiency Treatment market across various regions?
5) Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
6) What are the challenges and threats that are likely to act as a barrier to the growth of the Exocrine Pancreatic Insufficiency Treatment market?
7) What are the major opportunities that the companies can get to attain success in the world?
For Competitve Intelligence Do refer: https://www.datamintelligence.com/competitive-intelligence
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency Treatment Market to Surge with 6.4% CAGR, Global Revenue to Exceed USD 5.37 billion by 2031 - AbbVie, Codexis Inc., Nestle. here
News-ID: 3767696 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031.
Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The…
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031).
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric…
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of…
United States Biomedical Embedded Systems 2024-2031: Applications in Wearable De …
Global Biomedical Embedded Systems Market reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.
Biomedical embedded systems are specialized hardware-software integrated platforms used in medical devices and healthcare applications. These systems support real-time monitoring, diagnostics, therapeutic interventions, wearable devices, and hospital automation. The market is growing due to rising demand for connected healthcare,…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
